OneMedNet's Q3 Revenue Surge Signals iRWD Traction but Liquidity Concerns Persist

What happened

OneMedNet announced preliminary Q3 2026 revenue of approximately $1 million, a 242% sequential increase and 465% year-over-year growth, driven primarily by its iRWD data delivery contracts after the BEAM platform was decommissioned in May 2025. While the top-line improvement is encouraging and suggests early traction in the imaging real-world data pivot, the figure remains modest relative to the company's cash burn and accumulated deficit of over $100 million. The prior DeepValue master report maintained a SELL stance due to acute liquidity constraints (only $0.1 million cash and $1.6 million Bitcoin as of June 2025), a going-concern warning, and Nasdaq noncompliance overhang. The preliminary revenue announcement does not address whether the quarter generated positive operating cash flow or improved the balance sheet, leaving key solvency risks unresolved. Investors should treat the revenue jump as a positive signal of product-market fit but not yet a reversal of the company's precarious financial position.

Implication

The sharp revenue acceleration confirms that the iRWD offering can win fixed-fee contracts, which is a necessary step toward viability. However, one quarter of $1 million revenue is still far below the scale needed to offset operating expenses and cash burn, and management has not disclosed margin or cash flow impacts. The going-concern warning and dependence on dilutive financing remain significant overhangs; any capital raise to fund operations could substantially dilute existing shareholders. Nasdaq compliance deadlines are looming, and failure to regain compliance could force a reverse split or delisting, adding risk. Investors should monitor subsequent quarters for sustained iRWD revenue above $1 million, improving gross margins, and a clear path to positive operating cash flow before reconsidering the SELL thesis.

Thesis delta

The preliminary Q3 revenue of $1 million is a positive data point that iRWD is gaining traction, but it falls short of the two consecutive quarters >$1M iRWD revenue threshold noted in the master report to upgrade to HOLD. With no update on liquidity, margins, or compliance, the SELL thesis remains intact; we are now watching for sustainability and cash generation.